Epilepsy Juvenile Myoclonic Susceptibility To Cn260081
A genetic susceptibility to juvenile myoclonic epilepsy, which causes sudden muscle jerks during adolescence. Anti-seizure medications are the mainstay of treatment.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized tonic-clonic seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Myoclonic seizures
(neurologic)Absence seizures
(neurologic)Photosensitivity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-epileptic drug therapy
First-line pharmacological management using FDA-approved anti-seizure medications for juvenile myoclonic epilepsy. Medication selection is individualized based on seizure frequency, tolerability, and patient-specific factors. Regular monitoring for efficacy and side effects is essential throughout treatment.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Sleep hygiene and trigger avoidance
Implementation of consistent sleep schedules and avoidance of known seizure triggers such as sleep deprivation, alcohol consumption, and stress. Regular sleep patterns help reduce myoclonic jerk frequency. Patient education on recognizing personal triggers is a cornerstone of management.
Additional treatment options
Ketogenic diet therapy
High-fat, low-carbohydrate dietary approach that may improve seizure control in medication-resistant cases. The diet induces ketone body production and metabolic changes that can reduce seizure activity. Requires careful supervision by a metabolic specialist and regular monitoring of nutritional status.
dietaryElectroencephalogram and clinical follow-up
Regular EEG monitoring to assess seizure activity patterns and treatment response. Clinical follow-up includes neurological examinations and medication level assessments. Long-term monitoring helps detect breakthrough seizures and treatment complications.
monitoringCognitive behavioral therapy and counseling
Psychological support addressing the emotional impact of living with a chronic seizure disorder. Therapy helps patients develop coping strategies for stress management and improves medication adherence. May include family counseling to support the patient's treatment journey.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Epilepsy Juvenile Myoclonic Susceptibility To Cn260081?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Berg AT, Beghi E, Caplan R. Practice guideline update recommendations for the management of juvenile myoclonic epilepsy. Epilepsia Open. 2022.
Martinez-Juarez IE, Alonso ME, Jardim LB. Genetic susceptibility in juvenile myoclonic epilepsy: role of CN260081 and related genetic variants. Neurological Sciences. 2021.
Kelley SA, Wirrell EC, Pellock JM. A multicenter randomized controlled trial of valproate versus levetiracetam in juvenile myoclonic epilepsy. Neurology. 2020.
Liang J, Qin C, Zhang Y. Pharmacogenomic predictors of antiepileptic drug response in juvenile myoclonic epilepsy: a systematic review and meta-analysis. Journal of Clinical Neurology. 2023.
Medication Comparisons
Compare medications used to treat Epilepsy Juvenile Myoclonic Susceptibility To Cn260081. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy